TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/16/2025
Back to search
Official data from USPTO
MELOXI-CARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
07/23/2025
Trademark type
Word
Nice classes
5
Filing date
11/29/2022
Registration date
12/31/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/31/2024
Last transaction
07/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Calgary, Alberta, CA
Examiner
AURAND, MEGAN
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Alberta Veterinary Laboratories Ltd.
Representatives
Deborah J. Peckham Barclay Damon LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pain relief preparations for veterinary purposes
Publications
History of USPTO decisions and trademark events.
35 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/16/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/16/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/16/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/31/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/12/2024
PUBO
PUBLISHED FOR OPPOSITION
11/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/23/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/06/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/06/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/14/2024
GNSL
LETTER OF SUSPENSION E-MAILED
05/14/2024
CNSL
SUSPENSION LETTER WRITTEN
05/14/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/13/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/13/2024
ALIE
ASSIGNED TO LIE
05/13/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/19/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
10/10/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
10/10/2023
CNSI
SUSPENSION INQUIRY WRITTEN
10/10/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/10/2023
GNSL
LETTER OF SUSPENSION E-MAILED
04/10/2023
CNSL
SUSPENSION LETTER WRITTEN
04/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/20/2023
GNRT
NON-FINAL ACTION E-MAILED
03/20/2023
CNRT
NON-FINAL ACTION WRITTEN
03/20/2023
DOCK
ASSIGNED TO EXAMINER
03/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/21/2022
NWAP
NEW APPLICATION ENTERED
12/02/2022
Continuous trademark protection
Get notified about every new filing that threatens MELOXI-CARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.